Skip to content

Visiobiane Anti-age Effects on Vision Parameters

Study of the Effects of Visiobiane Anti-age Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00449917
Enrollment
30
Registered
2007-03-21
Start date
2006-09-30
Completion date
2007-11-30
Last updated
2011-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Pigment Optical Density

Keywords

visual caracteristics, macular pigment optical density, visual acuity, contrast sensibility, lutein, docosahexaenoic acid (DHA)

Brief summary

The purpose of this study is to determine the benefits of Visiobiane Anti-age dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.

Detailed description

Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15 subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age). They will be supplemented for 24 weeks

Interventions

DRUGlutein
DRUGDHA

Sponsors

PiLeJe
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
45 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy caucasian men * age : 45-55 * BMI \< 25

Exclusion criteria

* non healthy * retinian and/or visual anomaly * Ocular media not clear enough to allow good fundus photography

Design outcomes

Primary

MeasureTime frame
macular pigment optical density

Secondary

MeasureTime frame
contrast sensibility
visual acuity
seric carotenoids concentrations
total antioxidant capacity
influence of SR-B1 genetic polimorphism

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026